CA2425563A1 - Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence - Google Patents

Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence Download PDF

Info

Publication number
CA2425563A1
CA2425563A1 CA002425563A CA2425563A CA2425563A1 CA 2425563 A1 CA2425563 A1 CA 2425563A1 CA 002425563 A CA002425563 A CA 002425563A CA 2425563 A CA2425563 A CA 2425563A CA 2425563 A1 CA2425563 A1 CA 2425563A1
Authority
CA
Canada
Prior art keywords
denotes
dimethylamino
phen
iminoimidazolidine
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002425563A
Other languages
English (en)
French (fr)
Inventor
Franz Esser
Pascale Arielle Jane-Josee Pouzet
Hisato Kitagawa
Kenji Sakai
Ikunobu Muramatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2425563A1 publication Critical patent/CA2425563A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002425563A 2000-10-14 2001-10-11 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence Abandoned CA2425563A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10051005 2000-10-14
DE10051005.1 2000-10-14
PCT/EP2001/011764 WO2002032876A2 (de) 2000-10-14 2001-10-11 Neue m-amino-phenylimino-imidazolidin-derivate zur behandlung der harninkontinenz

Publications (1)

Publication Number Publication Date
CA2425563A1 true CA2425563A1 (en) 2002-04-25

Family

ID=7659815

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002425563A Abandoned CA2425563A1 (en) 2000-10-14 2001-10-11 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence

Country Status (23)

Country Link
EP (1) EP1328517A2 (pl)
JP (1) JP2004511547A (pl)
KR (1) KR20030046503A (pl)
CN (1) CN1471514A (pl)
AR (1) AR035923A1 (pl)
AU (1) AU2002215943A1 (pl)
BG (1) BG107711A (pl)
BR (1) BR0114603A (pl)
CA (1) CA2425563A1 (pl)
CZ (1) CZ20031333A3 (pl)
DE (1) DE10150312A1 (pl)
EA (1) EA200300460A1 (pl)
EC (1) ECSP034517A (pl)
EE (1) EE200300177A (pl)
HU (1) HUP0302245A3 (pl)
IL (1) IL155338A0 (pl)
MX (1) MXPA03003162A (pl)
NO (1) NO20031697L (pl)
PL (1) PL361359A1 (pl)
SK (1) SK4342003A3 (pl)
WO (1) WO2002032876A2 (pl)
YU (1) YU28203A (pl)
ZA (1) ZA200302345B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806811A1 (de) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz

Also Published As

Publication number Publication date
AU2002215943A1 (en) 2002-04-29
PL361359A1 (pl) 2004-10-04
EP1328517A2 (de) 2003-07-23
EA200300460A1 (ru) 2004-02-26
WO2002032876A2 (de) 2002-04-25
HUP0302245A2 (hu) 2003-10-28
NO20031697L (no) 2003-05-26
NO20031697D0 (no) 2003-04-11
YU28203A (sh) 2006-05-25
BG107711A (en) 2004-02-27
CN1471514A (zh) 2004-01-28
HUP0302245A3 (en) 2004-01-28
MXPA03003162A (es) 2004-12-06
IL155338A0 (en) 2003-11-23
DE10150312A1 (de) 2002-07-04
CZ20031333A3 (cs) 2003-08-13
JP2004511547A (ja) 2004-04-15
SK4342003A3 (en) 2003-10-07
WO2002032876A3 (de) 2002-07-18
ECSP034517A (es) 2003-04-25
BR0114603A (pt) 2003-10-14
AR035923A1 (es) 2004-07-28
EE200300177A (et) 2003-08-15
KR20030046503A (ko) 2003-06-12
ZA200302345B (en) 2004-04-23

Similar Documents

Publication Publication Date Title
US4880810A (en) Quinazolinediones and pyridopyrimidinediones
US4532331A (en) 1-Benzyl-2-aminomethyl imidazole derivatives
SU1380614A3 (ru) Способ получени производных арилтиазолов или их хлористоводородных или бромистоводородных солей
PL166214B1 (pl) Sposób wytwarzania nowych pochodnych indolu PL PL PL PL PL PL PL
CA2375843A1 (en) Compositions and methods for inhibiting cell death
HU187478B (en) Process for preparing new imidazolyl-phenyl-amidines and pharmaceutical compositions containing thereof
AU2003257300A1 (en) Amino benzothiazole compounds with nos inhibitory activity
US4719223A (en) Imidazolethiol dopamine-beta-hydroxylase inhibitors
Cordi et al. Design, synthesis, and structure-activity Relationships of a new series of. alpha.-adrenergic agonists: spiro [(1, 3-diazacycylpent-1-ent)-5, 2'-(1', 2', 3', 4'-tetrahydronaphthalene)]
US6602897B2 (en) m-Amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
CA2425563A1 (en) Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
EP0366006B1 (en) Pyridylketoxime ether compound and pharmaceutical composition containing it
RU2491278C2 (ru) Гетероциклические производные индана, используемые для снятия боли и лечения состояний, подобных глаукоме
WO1995013064A1 (en) 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
CA2437809A1 (en) Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence
US20020169193A1 (en) Alkylphenyliminoimidazolidine derivatives for treating urinary incontinence
CA1271767A (en) DOPAMINE-.beta.-HYDROXYLASE INHIBITORS
SK8652003A3 (en) Piperazinylcarbonylquinoline and piperazinylcarbonylisoquinoline derivative, process for the preparation thereof, use and pharmaceutical composition comprising same
US4772723A (en) Dopamine β-hydroxylase inhibitors
US4873357A (en) Trifluoro acetyl-cyano-aniline intermediates for dopamine-βhydroxylase inhibitors
EP1140891A1 (en) 1,4-diazacycloheptane compounds, process for their preparation, and their use as medicaments
US4863944A (en) Dopamine-β-hydroxylase inhibitors
WO1997007795A2 (en) 1-[4-(4'-sulfanilyl)phenyl]urea and derivatives for the treatment of leishmaniasis
AU607866B2 (en) LO/CO inhibiting benzoxazolones
IE42462B1 (en) 1-methyl-2-nitro-imidazole-5-methanol derivatives

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued